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ABSTRACT 
 
Background 
The detrimental impact of dementia upon patient health related quality of life (HRQL) is well 
established as is the importance of improving HRQL. However, relatively little is known about 
the natural history of HRQL in dementia and those factors influencing it. This limited 
knowledge potentially restricts the evaluation of the efficacy of interventions designed to 
improve HRQL. One such area concerns the relationship between HRQL and patient insight. It 
remains unclear what impact, if any, impaired insight has upon a patient’s HRQL. The present 
study aimed to investigate the relationship between insight and HRQL in a sample of patients 
with Alzheimer’s disease (AD) and their carers. 
 
Methods 
256 patients with AD were recruited as part of AddNeuroMed, a multi-centre European AD 
biomarkers study. Of these 174 completed a quality of life measure in addition to a 
comprehensive battery of clinical and neuropsychological assessments.  
 
Results 
Insight was found to be differentially related to patient perceptions of HRQL in mild and 
moderate dementia. Within moderate dementia impaired insight was associated with better 
perceived HRQL. Conversely cognition, but not insight, was associated with impaired HRQL 
in mild dementia. Insight was not found to be associated with carer perceptions of patient 
HRQL.  
 
Conclusion 
Impairment of insight is associated with better HRQL in moderate dementia. This finding has 
implications for interventions which focus on increasing patient awareness and orientation as 
impairment of insight appears to have a positive impact upon HRQL.  
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Introduction 
 
The past ten years have seen increasing attention paid to the investigation of Health Related 
Quality of Life (HRQL) in dementia.[1] The behavioural, and psychological symptoms 
experienced by patients with dementia have a profoundly negative impact upon quality of life 
in people with dementia.[2-9] Improving quality of life for people with dementia has become a 
priority in dementia care and HRQL has been frequently suggested as an indicator of the 
effectiveness of both psychosocial and pharmacological interventions.[10,11] Although 
increasing attention is being paid to HRQL in dementia we remain largely ignorant about who 
suffers most loss of HRQL and the factors influencing this.[12]  
 
We need to understand what determines good and bad HRQL in dementia if we are to develop 
and evaluate interventions to improve HRQL. A better understanding of factors influencing 
HRQL in dementia might enable us to identify those most at risk of declining HRQL so 
allowing monitoring and provision of appropriate treatment when necessary.   
 
One such area in need of further investigation is the relationship between HRQL and insight. It 
seems intuitive that being aware of decline might adversely impact on HRQL, and relatives 
may resist clinicians discussing diagnosis on the grounds that this might negatively impact on 
the patient. However it remains unclear what (if any) is the effect of a person with dementia’s 
insight into their condition has on their HRQL. Investigations into the relationship between 
patient insight and HRQL have produced equivocal results,[13,14] albeit with relatively small 
samples. Ready et al. [14] found no relationship between clinician ratings of insight and either 
patient or carer measures of HRQL in a sample of 26 people with Alzheimer’s disease (AD). 
Consistent with Ready et al.’s study, HRQL was not found to differ between patients with 
impaired insight and those with full awareness in a sample of 48 people with mild AD.[13] 
However when the relationship between patient and carer measures of HRQL was examined, 
scores were found to correlate within the full insight sample but not in those with impaired 
insight. Impairment of insight may have led people with dementia to perceive their HRQL 
more positively than it was perceived by their carer, as suggested by the lack of association 
between the two scores.   
 
We therefore sought to examine the relationships between HRQL and insight in a sample of 
people with Alzheimer’s disease and their carers. We explored how these relationships varied 
with degree of cognitive impairment in an attempt to determine the natural course of the 
relationship between insight and HRQL with progression of dementia. We hypothesised that 
people with dementia with impaired insight would perceive their HRQL to be better than those 
with full insight. 
 
 
Methods 
 
Two hundred and fifty six patients with mild to moderate Alzheimer’s disease were recruited 
as part of AddNeuroMed, a multi-centre European AD biomarkers study.[15] The six 
participating clinical centres included University Hospitals in Kuopio, Perugia, Lodz, 
Thessaloniki, Toulouse and London. Subjects were people with dementia who attended local 
dementia clinics and had received a diagnosis of AD.   
 
Inclusion criteria were: possible or probable AD according to the NINCDS-ARDA and DSM 
IV; a MMSE score of between 12-30; and age 65 years or above. Patients with significant 
neurological or psychiatric illness other than AD or any significant unstable systematic illness 
or organ failure were not included in the study. 
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A comprehensive semi-structured evaluation was conducted with all patients and caregivers 
assessing cognition (Mini-Mental State Examination (MMSE),[16] Alzheimer’s Disease 
Assessment Scale – Cognitive Subscale (ADAS-Cog),[17] function (Alzheimer’s Disease 
Cooperative Study-Activities of Daily Living Inventory (ADCS-ADL),[18] behavioural and 
psychological symptoms (Neuropsychiatric Inventory (NPI)[19] and health related quality of 
life (DEMQOL)[20,21] (see table 1 for descriptive data). The DEMQOL consists of a 28-item 
interviewer-administered questionnaire that is self-reported by the person with dementia 
(DEMQOL) and a 31-item interviewer-administered questionnaire that is proxy-reported by a 
caregiver (DEMQOL-Proxy).  For all assessments a higher score indicated better functioning 
with the exception of the ADAS-Cog where a higher score suggested poorer cognitive 
function. A total of 174 patients had either a DEMQOL-Proxy score or a self-rated DEMQOL 
score or both (155 proxy, 162 self). 
 
Two measures of patient insight were employed. The first was a dichotomous researcher rating 
of patient insight; patients were rated as having good or partial/little insight (rater scored 
insight). The second measure of insight was based on the patient’s response to the question ‘Do 
you have problems with memory or thinking?’ Possible responses included ‘yes’, ‘no’ and 
‘don’t know’ (self scored insight). These questions were derived from the Clinical Dementia 
Rating Scale worksheet. [22] 
 
The study was approved by the South London and Maudsley NHS Foundation Trust ethics 
committee and appropriate ethical approval was gained in all other participating countries. 
 
 
Results 
 
The final dataset included 174 patients with an MMSE score between 12 and 30. In order to 
examine the consistency of relationships between HRQL and insight with dementia stage, the 
sample was stratified by MMSE score to produce two groups: mild (MMSE score between 21 
and 30) and moderate dementia (MMSE score between 12 and 20). All further cognitive 
analyses used scores from the ADAS-Cog which provides a more detailed assessment of 
cognition than the MMSE. The sample demographic data are shown in table 1 along with mean 
MMSE, ADAS-Cog and DEMQOL scores. 
 
Table 1. Sample demographic data and MMSE, ADAS-Cog and patient and proxy 
DEMQOL scores 
 N Age 
(sd) 
M:F Education 
Years (sd) 
MMSE 
(sd) 
ADAS-
Cog 
(sd) 
Duration 
of illness 
(sd) 
DEMQOL 
Patient 
DEMQOL 
Proxy 
All 174 77.2 
(6.5) 
67:107 8.4 (4.1) 20.6 
(4.9) 
24.8 
(9.9) 
4.1 (3.1) 90.8 (15.7) 97.8 (13.7) 
MMSE 
12-20 
79 78.5 
(6.5) 
30:49 7.3 (3.8) 16.1 
(2.5) 
30.9 
(8.2) 
4.3 (3.1) 92.0 (16.5) 98.9 (11.7) 
MMSE 
21-30 
95 75.9 
(6.3) 
37:58 9.2 (4.1) 24.5 
(2.4) 
19.5 
(8.0) 
3.9 (3.2) 89.9 (14.3) 97.2 (15.0) 
 
 
We first established that a range of demographic and clinical characteristics were not 
associated with HRQL and hence were not acting as confounders in subsequent analyses. We 
found no association between HRQL and age, marital status, years of education, duration of 
illness, activities of daily living and carer characteristics, none of which were statistically 
significant (p<0.05).  
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Cognition and HRQL 
Previous studies of HRQL consistently find little impact of cognition per se on HRQL,[12] we 
confirmed this finding in our dataset as no significant correlation was found between cognition 
and HRQL in the sample as a whole (Pearson correlation between ADAS-Cog score and 
DEMQOL r = -.07, p = .41, DEMQOL-Proxy r = -.14, p = .08).  
 
However, Alzheimer’s disease is a chronic disorder and the relationship between HRQL and 
symptoms may change as the disease progresses. To test this relationship further, correlations 
between ADAS-Cog scores and HRQL scores within the mild and moderate dementia samples 
were calculated separately. No significant correlations were found within the moderate sample 
(DEMQOL r = -0.001, p =0 .995, DEMQOL-Proxy r = -0.011, p = 0.928), however ADAS-
Cog scores were significantly correlated with HRQL in the mild sample (DEMQOL r = -0.27, 
p = 0.010, DEMQOL-Proxy r  = -0.354, p = 0.001). The relationships between cognition and 
HRQL are presented in figure 1. 
 
Figure 1. Scatterplot of ADAS-Cog and Patient DEMQOL Scores by MMSE Group 
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Behavioural and Psychological Symptoms and HRQL 
Previous research has shown that behavioural and psychological symptoms such as depression, 
irritability and agitation have a profound negative impact on HRQL.[12] We confirmed this 
finding in this large cross-European study. The NPI was used as a measure of behavioural and 
psychological symptoms and, as predicted, total NPI scores strongly correlated with both 
patient and carer DEMQOL scores (DEMQOL: r  = -0.190, p = 0.016, DEMQOL-Proxy: r = -
0.244, p = 0.002). The presence of behavioural and psychological symptoms was associated 
with significantly poorer HRQL. We then sought to determine which sets of behavioural and 
psychological symptoms impacted most on HRQL. Moderately strong relationships were found 
between depression and DEMQOL score (r = -0.425, p <0.001), and between depression and 
anxiety and DEMQOL-Proxy scores (depression: r = -0.391, p <0.001, anxiety: r = -0.396, p 
<0.001).  
 
Correlations between NPI scores and HRQL were examined within the mild and moderate 
dementia samples to explore the consistency of the relationships between NPI scores and 
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HRQL across dementia stages. Within the mild sample hallucinations were highly correlated 
with self-report (r = -0.314, p =0.002) and proxy-reports (r = -0.384, p 0.001). Depression and 
anxiety were again found to correlate moderately strongly with DEMQOL-Proxy score 
(depression: r = -0.341, p = 0.002, anxiety: r = -0.476, p <0.001). Within the moderate sample 
DEMQOL was strongly correlated with depression (r = -0.580, p <0.001) while irritability and 
depression were correlated with DEMQOL-Proxy scores (r = -0.376, p = 0.001, r = -0.486, p 
<0.001 respectively). For both mild and moderate dementia, then, we find strong correlations 
between behavioural and psychological symptoms and HRQL.  
 
Insight, cognition and HRQL 
We then investigated the relationship between insight and both HRQL and cognition. We 
hypothesised that HRQL would be impaired in those with good insight and, as a secondary 
hypothesis, that those with more severe cognitive impairment would have the least insight. 
 
Table 2 Quality of Life and Cognition by Insight Group 
 Self Scored Insight  Rater Scored Insight  
 Good 
Insight 
Impaired 
Insight 
T-Test Good 
Insight 
Impaired 
Insight 
T-Test 
12-20 MMSE       
No 59 19  24 54  
% 76.0% 24.0%  30.8% 69.2%  
DEMQOL 96.7 99 t(68) = 2.160  
p = 0.010 
84.7 95.8 t(68)=-2.741  
p = 0.008 
DEMQOL-
Proxy 
89.6 105.9 t(68)=2.808  
p = 0.006 
95.1 100.5 t(68)=-1.842  
p = 0.070 
ADAS COG 30.4 32.5 t(76)= .989 
 p = 0.327 
27.6 32.3 t(76)=-2.423  
p = 0.018 
21-30 MMSE       
No 74 20  54 40  
% 77.9% 21.1%  57.4% 42.6%  
DEMQOL 89 93 t(88) =1.056  
p = 0.294 
88.4 92.3 t(88)=-1.270  
p = 0.207 
DEMQOL-
Proxy 
96.9 97.8 t(80)=.230  
p = 0.818 
96.7 97.6 t(80)=-.269 
 p = 0.789 
ADAS COG 18.6 22.9 t(92)= 2.155  
p = 0.034 
17 22.8 t(92)=-3.676 
 p < 0.001 
Total sample       
No 133 39  79 94  
% 77.3% 22.7%  45.7% 54.3%  
DEMQOL 89.3 96.1 t(159) = 2.406  
p = 0.017 
87.4 94.3 t(171)=4.724  
p < 0.001 
DEMQOL-
Proxy 
96.6 101.4 t(150)=1.726 
p = 0.086 
95.9 99.3 t(151)=-1.550 
p = 0.123 
ADAS COG 24 27.5 t(170)=2.102  
p = 0.037 
20.6 28.2 t(171)=-5.452 
p < 0.001 
 
As shown in table 2, and in agreement with our hypothesis, HRQL was rated as higher in those 
with impaired insight, although only in the moderate dementia group (a trend for proxy rating 
in the rater scored insight group, but significant for all other analyses). HRQL did not differ 
according to insight in those with mild dementia.   
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In order to investigate whether impairment of patient insight was associated with worse 
cognition, ADAS-Cog scores were compared between insight groups using independent t-tests. 
Those with impaired insight had more severe cognitive deficit in both moderate and mild 
groups (non significant difference for moderate dementia and self scored insight but highly 
significant for all other comparisons).    
 
Multivariate Analyses  
Thus far we have established that cognition, behavioural and psychological symptoms, and 
insight are all associated with HRQL in dementia. In order to determine the relative 
contributions of each of these variables to the explanation of variance in HRQL, a series of 
regression analyses were performed. Separate regressions were performed for DEMQOL and 
DEMQOL-Proxy scores within each MMSE group. Separate regressions were performed using 
the rater scored and self scored insight measures in order to avoid the problem of multi-
collinearity. The adjusted R squared and standardised regression weights are shown in tables 3 
and 4. 
 
Table 3.Regression Models of Factors Predicting Patient DEMQOL scores 
 DEMQOL (MMSE 12-20) Beta coefficient  R square Adjusted R 
square 
Significance 
  0.365 0.336 <0.001 
ADAS-Cog -0.079 (p=0.438)    
NPI depression score -0.505 (p<0.000)    
Rater scored insight  0.245 (p=0.022)    
     
DEMQOL (MMSE 21-30)     
  0.231 0.204 <0.001 
ADAS-Cog -0.403 (p<0.001)    
NPI hallucinations score -0.255 (p=0.009)    
Rater scored insight 0.243 (p=0.020)    
     
DEMQOL (MMSE 12-20) Beta coefficient  R square Adjusted R 
square 
Significance 
  0.355 0.325 <0.001 
ADAS-Cog -0.051 (p=0.616)    
NPI depression score -0.535 (p<0.000)    
Self scored insight -0.211 (p=0.040)    
     
DEMQOL (MMSE 21-30)     
  0.218 0.109 <0.001 
ADAS-Cog -0.365 (p<0.001)    
NPI hallucinations score -0.289 (p=0.003)    
Self scored insight -0.203 (p=0.042)    
     
 
Depression and insight significantly predicted DEMQOL scores in the moderate dementia 
group but cognition was not found to predict HRQL. Both cognition and insight predicted 
patient HRQL in mild dementia along with hallucinations. The relationship between HRQL 
and insight in the 21-30 MMSE group was unexpected as this relationship was not present 
within the bivariate analyses. However there is a strong relationship between insight and 
cognition in this sample. In order to test whether the relationship seen between insight and 
HRQL in the 21-30 MMSE group was a product of the relationship between cognition and 
insight, insight was entered into stepwise regression models alone in the first step. Insight 
significantly predicted HRQL in the 12-20 MMSE group only, insight did not significantly 
predict HRQL in the 21-30 MMSE sample for either measures of insight.   
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Table 4. Regression Models of Factors Predicting Proxy DEMQOL scores 
DEMQOL-Proxy (MMSE 12-20) Beta coefficient  R square Adjusted R 
square 
Significance 
  0.191 0.141 0.008 
ADAS-Cog -0.055 (p=0.641)    
NPI depression score -0.292 (p=0.017)    
NPI anxiety score -0.166 (p=0.160)    
Rater Scored insight 0.184 (p=0.131)    
     
DEMQOL-Proxy (MMSE 21-30)     
  0.443 0.406 <0.001 
ADAS-Cog -0.189 (p<0.001)    
NPI hallucinations score -0.126 (p=0.184)    
NPI depression score -0.270 (p=0.003)    
NPI anxiety score -0.386 (p<0.001)    
Rater Scored insight 0.119 (p=0.211)    
     
DEMQOL-Proxy (MMSE 12-20) Beta coefficient  R square Adjusted R 
square 
Significance 
  0.230 0.182 0.002 
ADAS-Cog -0.013 (p=0.907)    
NPI depression score -0.298 (p=0.011)    
NPI anxiety score -0.137 (p=0.232)    
Self Scored insight -0.298 (p=0.020)    
     
DEMQOL-Proxy (MMSE 21-30)     
  0.426 0.388 <0.001 
ADAS-Cog -0.313 (p=0.001)    
NPI depression score -0.271 (p=0.003)    
NPI hallucinations score -0.133 (p=0.166)    
NPI anxiety score -0.385 (p<0.001)    
Self Scored insight -0.090 (p=0.316)    
     
 
Consistent with the patient-DEMQOL models, cognition was found to predict DEMQOL-
Proxy scores in the 21-30 MMSE sample only. NPI items significantly predicted HRQL in all 
models. Self Scored insight was found to predict DEMQOL-Proxy scores in the 12-20 MMSE 
group only. 
 
 
Discussion 
 
The present study aimed to investigate whether insight was associated with self and proxy-
reports of HRQL in Alzheimer’s disease. Few studies have undertaken such a large scale 
investigation of insight and HRQL using two measures of insight. We find that in moderate 
dementia only, impaired insight is associated with better HRQL but that in mild dementia there 
is no such association. In contrast, impaired cognition negatively impacts on HRQL only in 
those with mild dementia. Behavioural symptoms on the other hand have a negative impact on 
HRQL in both mild and moderate dementia.  
 
Summary of findings 
In line with previous research, demographic factors were not associated with HRQL and the 
presence of behavioural and psychological symptoms were associated with poorer HRQL;[12] 
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in both moderate and mild dementia. Lower cognition was correlated with lower HRQL in 
mild but not moderate dementia suggesting that declining cognition does not necessarily lead 
to reduced HRQL. The lack of relationship between cognition and HRQL in moderate 
dementia suggests either that patients are less aware of the cognitive difficulties they 
experience or that they have adapted and ‘regraded’ their expectations, accommodating to 
impairment. By changing goals and expectations patients may avoid distress produced by 
failure to perform tasks and activities previously considered achievable.[23]  
 
Insight and cognition are clearly related in AD, with impaired insight associated with poorer 
cognition, however in moderate dementia insight alone impacts on quality of life, whilst in 
mild dementia cognition impacts on quality of life. This finding is consistent with previous 
research in mild AD which failed to find any association between insight and HRQL.[14] 
 
Overall the findings suggest that insight plays a complex role in evaluations of HRQL in 
dementia. People with moderately severe dementia and impaired insight into their condition 
showed a tendency to perceive their quality of life as better. For those with mild dementia, and 
therefore potentially higher levels of insight, this protective effect was not observed.  
 
Implications 
The finding that impaired insight is associated with better HRQL suggests that impairment of 
insight may actually be protective for the person with dementia. Relatives often say as much. 
This raises questions about the management which should be provided for patients who lack 
awareness. Re-orientating patients to their situation through the use of therapies such as reality 
orientation, which repeatedly require the patient to acknowledge problems, may have the effect 
of increasing awareness and therefore reducing HRQL.  The effect of other therapies aimed at 
improving cognition such as cognitive stimulation [24] is of interest as a form of intervention 
potentially benefitting HRQL in mild dementia through improved cognition  
 
The observed relationship between cognition and quality of life in mild dementia highlights the 
need for monitoring of newly diagnosed patients for decline in HRQL with deteriorating 
cognition. Monitoring will allow appropriate intervention in order to improve HRQL. Helping 
patients with mild dementia to adjust their goals and expectations, accommodating their 
cognitive impairment, may improve quality of life for these patients. When a person 
experiences declines in their cognition their previous goals may become unrealistic, the gap 
between their present state and desired state widens reducing quality of life. Revising goals to 
be more achievable may help to improve quality of life [25].  
 
The results also have implications for research into health-related quality of life. When 
conducting research investigating the effectiveness of interventions on HRQL in dementia it 
may well be useful to measure insight.  
 
Limitations  
The present study has limitations which must be taken into consideration. First, the single item 
approach to measuring insight employed in the present study was relatively simplistic however 
both measures produced similar results providing validity for the measures. Second, this is a 
cross-sectional study and we cannot draw any conclusions regarding causality. A longitudinal 
investigation of HRQL and insight in dementia would be helpful to chart the natural history of 
HRQL in dementia and allow causal relationships to be investigated.  Finally, the study only 
included patients with an MMSE score of 12 and above. No conclusions can therefore be 
drawn about insight and HRQL in people with severe cognitive impairment in dementia. 
 
Conclusions 
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The findings from this study suggest that insight is an important determinant of HRQL for 
people with moderate dementia. This finding validates the anecdotal reports of relatives and 
suggests that lack of insight may act as a protective mechanism. Insight was found to have no 
impact on HRQL in mild dementia suggesting that clinicians should not be worried about 
discussing diagnosis and plans for the future with patients.  Behavioural and psychological 
symptoms were found to negatively impact on HRQL at all stages suggesting that clinicians 
should focus on alleviating these symptoms to improve quality of life.  
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